135 related articles for article (PubMed ID: 1663287)
21. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
[TBL] [Abstract][Full Text] [Related]
22. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
Mettenleiter TC; Klupp BG; Weiland F; Visser N
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines.
Vannier P; Cariolet R
Zentralbl Veterinarmed B; 1989 Sep; 36(7):515-26. PubMed ID: 2554623
[TBL] [Abstract][Full Text] [Related]
25. [Vaccination of sheep against Aujeszky's disease with a gI-deleted mutant].
Bruchhof BR; Straub OC
Dtsch Tierarztl Wochenschr; 1992 Aug; 99(8):322-5. PubMed ID: 1330479
[TBL] [Abstract][Full Text] [Related]
26. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
[TBL] [Abstract][Full Text] [Related]
27. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
Hopp W; Jungblut R
Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
[TBL] [Abstract][Full Text] [Related]
28. [Trial of vaccination against Aujeszky's disease].
Motovski A; Veselinova A; Dobrev V
Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
[TBL] [Abstract][Full Text] [Related]
29. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
Vannier P
Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
[TBL] [Abstract][Full Text] [Related]
30. [Vaccination in Aujeszky's disease on enzootic fattening farms].
Motovski A; Veselinova A; Shalamanov D
Vet Med Nauki; 1980; 17(4):23-9. PubMed ID: 6259802
[TBL] [Abstract][Full Text] [Related]
31. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
Mengeling WL; Brockmeier SL; Lager KM
Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
[TBL] [Abstract][Full Text] [Related]
34. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
Kit M; Kit S
Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
[TBL] [Abstract][Full Text] [Related]
35. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
36. Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions.
de Leeuw PW; van Oirschot JT
Vet Q; 1985 Jul; 7(3):191-7. PubMed ID: 2996210
[TBL] [Abstract][Full Text] [Related]
37. Vaccines against Aujeszky's disease: comparison of efficacy, DNA fingerprints and antibody response to glycoprotein I.
van Oirschot JT; Gielkens AL
Vet Q; 1987 Nov; 9 Suppl 1():37S-49S. PubMed ID: 2829410
[TBL] [Abstract][Full Text] [Related]
38. Parenteral and intranasal vaccination of fattening pigs against Aujeszky's disease (pseudorabies).
Pensaert M; Maes L
Zentralbl Veterinarmed B; 1984 Oct; 31(9):682-9. PubMed ID: 6097071
[No Abstract] [Full Text] [Related]
39. Vaccination against Aujeszky's disease: field experiences.
McCracken RM; McFerran JB; McParland PJ; McKillop ER
Vet Rec; 1984 Oct; 115(14):348-52. PubMed ID: 6093329
[TBL] [Abstract][Full Text] [Related]
40. Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs.
van Oirschot JT; Houwers DJ; Rziha HJ; Moonen PJ
J Virol Methods; 1988 Dec; 22(2-3):191-206. PubMed ID: 2851599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
